Gerald is an accomplished financial leader with over 20 years of global experience in financial management across complex, growth-oriented organizations. She brings deep expertise in building strong financial infrastructures that support operational excellence, strategic expansion, and long-term sustainability.

At UNIQ Trials, Gerald plays a pivotal role in strengthening the company’s financial foundations as it continues to scale as a global boutique CRO serving emerging and mid-size biotechs. His strategic oversight ensures disciplined growth, transparent reporting, and financial models that align with the realities of venture-backed and clinical-stage development programs.

While highly skilled in financial governance, forecasting, and risk management, he is equally known for his collaborative and people-centered leadership style. Gerald believes that strong financial stewardship is not only about numbers, but about enabling teams, supporting innovation, and building a resilient organization capable of advancing meaningful clinical development.

His enthusiasm, integrity, and commitment to making a positive contribution underpin UNIQ Trials’ mission to deliver high-quality, sponsor-focused clinical solutions while maintaining long-term financial strength.